124 results
8-K
EX-99.1
ALKS
Alkermes plc
7 Mar 24
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7:09am
Richard Pops, Chief Executive Officer of Alkermes. “Nancy’s appointment reflects the Board’s ongoing commitment to robust board refreshment
8-K
EX-2.1
zy0byc 4vsx
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
DFAN14A
skto0k1
26 Jun 23
Additional proxy materials by non-management
5:00pm
DFAN14A
qqgzn8im3
22 Jun 23
Additional proxy materials by non-management
4:33pm
DEFA14A
a1ej2iv4 k8
20 Jun 23
Additional proxy soliciting materials
7:11am
DEFA14A
4tds492pka1
13 Jun 23
Additional proxy soliciting materials
4:42pm
DEFA14A
ifw ytoxun9
13 Jun 23
Additional proxy soliciting materials
7:08am
DEFA14A
ddudhnz d9gv
7 Jun 23
Additional proxy soliciting materials
5:28pm
DEFA14A
qy32hpqb
6 Jun 23
Additional proxy soliciting materials
6:14am
8-K
EX-99.1
qaic1w2egh5h zz2js35
6 Jun 23
Alkermes Announces Final Award in Janssen Pharmaceutica Arbitration and Provides Updated Financial Expectations
6:10am
DEFA14A
4dbv4hsczt a2ifrf
25 May 23
Additional proxy soliciting materials
4:31pm
DEFC14A
756wedxfuynxl7t95y5
25 May 23
Proxy in contested solicitation
4:03pm
PRER14A
x24ud slxmesb5m9
19 May 23
Preliminary revised proxy
5:23pm
PREC14A
b8fqkqq3pa
8 May 23
Preliminary proxy with contested solicitation
4:34pm